Heparan sulfate proteoglycan expression in human lung-cancer cells

International Journal of Cancer

Volumn 74, Issue 3, 1997, Pages 335-345

  Nackaerts, Kris ^a   Verbeken, Erik ^b   Deneffe, Georges ^b   Vanderschueren, Bernadette ^a   Demedts, Maurits ^b   David, Guido ^a,c  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c CENTER FOR HUMAN GENETICS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARAN SULFATE; PERLECAN; PROTEOGLYCAN;

ANCHORAGE INDEPENDENT GROWTH; ANTIBODY SPECIFICITY; ARTICLE; CANCER CELL; CANCER INVASION; CELL ADHESION; CELL DIFFERENTIATION; CELL MOTILITY; EPITHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; LUNG CANCER; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FAMILY;

ADENOCARCINOMA; ANTIGENS, CD44; CARCINOMA, SQUAMOUS CELL; HEPARAN SULFATE PROTEOGLYCANS; HEPARITIN SULFATE; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MEDIASTINUM; NEOPLASM PROTEINS; PROTEOGLYCANS; TUMOR CELLS, CULTURED;

EID: 0030818085     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970620)74:3<335::AID-IJC18>3.0.CO;2-A     Document Type: Article

References (27)

1. AVIEZER, D., HECHT, D., SAFRAN, M., EISINGER, M., DAVID, G. and YAYON, A., Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis. Cell, 79, 1005-1013 (1994).
2. BEHRENS, J., MAREEL, M.M., VAN ROY, F.M. and BIRCHMEIER, W., Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J. Cell Biol., 108, 2435-2447 (1989).
3. BERNFIELD, M., KOKENYESI, R., KATO, M., HINKES, M.T., SPRING, J., GALLO, R.L. and LOSE, E.J., Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans. Ann. Rev. Cell. Biol., 8, 365-393 (1992).
4. BERNSTEIN, L.R. and LIOTTA, L.A., Molecular mediators of interactions with extracellular matrix components in metastasis and angiogenesis. Curr. Opin. Oncol., 6, 106-113 (1994).
5. COHEN, I.R., MURDOCH, A.D., NASO, M.F., MARCHETTI, D., BERD, D. and IOZZO, R.V., Abnormal expression of perlecan proteoglycan in metastatic melanomas. Cancer Res., 54, 5771-5774 (1994).
6. DAVID, G., Integral membrane heparan sulfate proteoglycans. FASEB J., 7, 1023-1030 (1993).
7. DAVID, G., BAI, X.M., VAN DER SCHUEREN, B., CASSIMAN, J.J. and VAN DEN BERGHE, H., Developmental changes in heparan sulfate expression: in situ detection with mAbs. J. Cell Biol., 119, 961-975 (1992).
8. HEINO, J., Integrin-type extracellular matrix receptors in cancer and inflammation. Ann. Med., 25, 335-342 (1993).
9. HOFMANN, M., RUDY, W., ZÖLLER, M., TOLG, C., PONTA, H., HERRLICH, P. and GÜNTHERT, U., CD44 splice variants confer metastatic behaviour in rats: homologous sequences are expressed in human tumor cell lines. Cancer Res., 51, 5292-5297 (1991).
10. INKI, P. and JALKANEN, M., The role of syndecan-1 in malignancies. Ann. Med., 28, 63-67 (1996).
11. Iozzo, R.V., COHEN, I.R., GRÄSSEL, S. and MURDOCH, A.D., The biology of perlecan: the multifaceted heparan sulphate proteoglycan of basement membranes and pericellular matrices. Biochem. J., 302, 625-639 (1994).
12. JACKSON, D.G., BELL, J.I., DICKINSON, R., TIMANS, J., SHIELDS, J. and WHITTLE, N., Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon. J. Cell Biol., 128, 676-685 (1995).
13. KATO, M., SAUNDERS, S., NGUYEN, H. and BERNFIELD, M., Loss of cell surface syndecan-1 causes epithelia to transform into anchorage-independent mesenchyme-like cells. Mol. Biol. Cell, 6, 559-576 (1995).
14. KIRJAVAINEN, J., LEPPÄ, S., HYNES, N.E. and JALKANEN, M., Translational suppression of syndecan-1 expression in Ha-ras transformed mouse mammary epithelial cells. Mol. Biol. Cell, 4, 849-858 (1993).
15. LEPPÄ, S., MALI, M., MIETTINEN, H.M. and JALKANEN, M., Syndecan expression regulates cell morphology and growth of mouse mammary epithelial tumor cells. Proc. nat. Acad. Sci. (Wash.), 89, 932-936 (1992).
16. LÉ VY, P., EMAMI, S., CHERQUI, G., CHASTRE, E., GESPACH, C. and PICARD, J., Altered expression of proteoglycans in E1A-immortalized rat fetal intestinal epithelial cells in culture. Cancer Res., 50, 6716-6722 (1990).
17. LIEBERSBACH, B.F. and SANDERSON, R.D., Expression of syndecan-1 inhibits cell invasion into type I collagen. J. biol. Chem., 269, 20013-20019 (1994).
18. MALI, M., ANDTFOLK, H., MIETTIENEN, H.M. and JALKANEN, M., Suppression of tumor cell growth by syndecan-1 ectodomain. J. biol. Chem., 269, 27795-27798 (1994).
19. NUMA, F., HIRABAYASHI, K., TSUNAGA, N., KATO, H., O'ROURKE, K., SHAO, H., STECHMANN-LEBAKKEN, C., VARANI, J., RAPRAEGER, A. and DIXIT, V.M., Elevated levels of syndecan-1 expression confer potent serum-dependent growth in human 293T cells. Cancer Res., 55, 4676-4680 (1995).
20. PILIA, G., HUGHES-BENZIE, R.M., MACKENZIE, A., BABAYAN, P., CHEN, E.Y., HUBER, R., NERI, G., CAO, A., FORABOSCO, A. and SCHLESSINGER, D., Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome. Nature (Genet.), 12, 241-247 (1996).
21. RAPRAEGER, A.C., The coordinated regulation of heparan sulfate, syndecans and cell behaviour. Curr. Opin. Cell Biol., 5, 844-853 (1993).
22. SCHIPPER, J.H., FRIXEN, U.H., BEHRENS, J., UNGER, A., JÄHNKE, K. and BIRCHMEIER, W., E-Cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res., 51, 6328-6337 (1991).
23. VLEMINCKX, K.L., DEMAN, J.J., BRUYNEEL, E.A., VANDENBOSSCHE, G.M., KEIRSEBILCK, A.A., MAREEL, M.M. and VAN ROY, F.M., Enlarged cell-associated proteoglycans abolish E-cadherin functionality in invasive tumor cells. Cancer Res., 54, 873-877 (1994).
24. VLODAVSKY, I., ELDOR, A., BAR-NER, M., FRIDMAN, R., COHEN, I.R. and KLAGSBRUN, M., Heparan sulfate degradation in tumor cell invasion and angiogenesis. Adv. exp. Med. Biol., 233, 201-210 (1988).
25. WHO, The World Health Organization histological typing of lung tumors. Amer. J. clin. Pathol., 77, 123-136 (1982).
26. WIJDENES, J., VOOIJS, W.C., CLEMENT, C., POST, J., MORARD, F., VITA, N., LAURENT, P., SUN, R.-X., KLEIN, B. and DORE, J.-M., A plasmocyte selective monoclonal antibody (B-B4) recognizes syndecan-1. Brit. J. Haematol., 94, 318-323 (1996).
27. WINTERBOURNE, D.J. and MORA, P.T., Cells selected for high tumorigenicity or transformed by simian virus 40 synthesize heparan sulfate with reduced degree of sulfation. J. biol. Chem., 256, 4310-4320 (1981).